Industrial Technologies and Life Sciences Investment Banking
We are an independent, globally active, investment banking firm specializing in mergers, acquisitions, company sales and corporate divestitures.
Investment Banking since 1992
We help global multinationals, prominent mid-sized companies and leading private equity firms to build and re-position their businesses through mergers and acquisitions, business sales / divestitures and strategic alliances.
With highly skilled professionals in New York, Chicago, London, Frankfurt, Paris, Zurich, Prague, Milan, Hong Kong and Beijing, we help clients facilitate transactions globally.
Years in Service
Completed M&A Transactions
Aggregate Deal Value ($)
M&A Deals are Cross-Border
Sell-side M&A Deals Sold to Strategic Buyers
Buy-side M&A Deals are Proprietary
Investment Banking and Financial Advisory
We help you grow through acquisition or merger. Leveraging our network to connect you with investment partners to provide for example, growth capital, market guidance, commercial partnership, and strategic insights. We help you realign your business or portfolio of businesses to better suit your corporate objectives.
Mergers & Acquisitions
For over 29 years EC M&A has advised firms across US, Europe and Asia on mergers, acquisitions and divestitures. Most corporate events have life changing consequences for those involved. We are proud of an enviable reputation for achieving and very often exceeding our client’s objectives.
Proactive buyside, growth through acquisitions
Buyside M&A is unpredictable and difficult. Having originally built our business providing buyside services to some of the largest multi-nationals we have honed our skills and processes to provide a unique tailored buyside offering. 90% of the companies we buy for our clients are non-auction bilateral transactions; enabling our clients to acquire high quality assets at reasonable prices.
Over 70% of our transactions involve the seller in one country and the buyer in another. Having worked for multi-nationals since 1992, we have an unrivalled global network of strategic buyers. By having our own people in three continents we shrink the globe for our clients seeking buyers or targets abroad.
Corporate Divestitures, and sale of non-core assets
Divestitures have their own complications. We have completed over 50 divestitures in the last 20 years providing us with the experience to ensure yours is completed smoothly.
Strategic funding solutions take shape in many forms. By leveraging our market knowledge, our network of both strategic investors, their venture arms, Private Equity, and Family office investors, we can access appropriate funding for most client requirements. We work with you to assess the most suitable development of your capital and debt structure, taking into consideration your needs now and in the future, and formulate a customized approach to achieve the best possible outcome for our clients and support them in their strategic goals.
We are a leader in advising industrial technology and life science clients. Our markets include:
- Test & Measurement / Instruments
- Gas Analysis, Detection, Monitoring
- Industry 4.0 / IIoT
- Water/Wastewater & Environmental
- Pumps, Valves & Flow control
- Non Destructive Testing / Metrology
- Optics & Photonics
- PPE, Workwear, Safety & Security
- General Industrial Products
- Energy (Oil & Gas and Power)
- Transportation & Aerospace
- Specialty Chemicals and Ingredients
Life Sciences and Medical Technologies:
- Analytical Instruments
- Bioprocessing Technologies
- Life Science Research Tools
- Medical Devices
- Pharmaceutical Production
Circular Economy Player Primo1D has raised €15.4 million in a Series C equity raise funding led by French Sovereign Fund Bpifrance alongside a new VC investor Innovacom
Highly innovative and patented RFID tag in a proprietary and unique form factor – a textile yarn, E-Thread
Leak detection solutions
Particulate monitors, meteorological instruments, and environmental software